These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 36026578)
1. Antihypertension Nanoblockers Increase Intratumoral Perfusion of Sequential Cytotoxic Nanoparticles to Enhance Chemotherapy Efficacy against Pancreatic Cancer. Bian S; Dong H; Zhao L; Li Z; Chen J; Zhu X; Qiu N; Jia X; Song W; Li Z; Zheng S; Wang H; Song P Adv Sci (Weinh); 2022 Oct; 9(29):e2201931. PubMed ID: 36026578 [TBL] [Abstract][Full Text] [Related]
2. Prodrug nanoparticles rationally integrating stroma modification and chemotherapy to treat metastatic pancreatic cancer. Wang L; Liu Z; Zhou Q; Gu S; Liu X; Huang J; Jiang H; Wang H; Cao L; Sun J; Shen Y; Meng H; Liu X Biomaterials; 2021 Nov; 278():121176. PubMed ID: 34656882 [TBL] [Abstract][Full Text] [Related]
3. Peritumoral implantation of hydrogel-containing nanoparticles and losartan for enhanced nanoparticle penetration and antitumor effect. Shen H; Gao Q; Ye Q; Yang S; Wu Y; Huang Q; Wang X; Sun Z Int J Nanomedicine; 2018; 13():7409-7426. PubMed ID: 30519023 [TBL] [Abstract][Full Text] [Related]
4. Partial ligand shielding nanoparticles improve pancreatic ductal adenocarcinoma treatment via a multifunctional paradigm for tumor stroma reprogramming. Zhao T; Zhang R; He Q; Zhou H; Song X; Gong T; Zhang Z Acta Biomater; 2022 Jun; 145():122-134. PubMed ID: 35381402 [TBL] [Abstract][Full Text] [Related]
5. Chemically engineered mTOR-nanoparticle blockers enhance antitumour efficacy. Tang H; Dilimulati D; Yang Z; Zhou K; Chen X; Sun R; Wang N; Liang Z; Bian S; Zhao J; Song P; Zheng S; Wang H; Xie H EBioMedicine; 2024 May; 103():105099. PubMed ID: 38604089 [TBL] [Abstract][Full Text] [Related]
6. Gradient tumor microenvironment-promoted penetrating micelles for hypoxia relief and immunosuppression reversion in pancreatic cancer treatment. Luo Y; Li C; Zhang Y; Liu P; Chen H; Zhao Z; Wang Y; Zhou Z; Song H; Su B; Li C; Li X; Zhang T; You H; Wu Y; Tian Z; Zhang S; Guo Y; Fan H; Chen Q; Jiang C; Sun T Acta Biomater; 2023 Sep; 167():387-400. PubMed ID: 37276955 [TBL] [Abstract][Full Text] [Related]
7. Nitric oxide-induced stromal depletion for improved nanoparticle penetration in pancreatic cancer treatment. Chen X; Jia F; Li Y; Deng Y; Huang Y; Liu W; Jin Q; Ji J Biomaterials; 2020 Jul; 246():119999. PubMed ID: 32247201 [TBL] [Abstract][Full Text] [Related]
8. Injectable hybrid hydrogels enable enhanced combination chemotherapy and roused anti-tumor immunity in the synergistic treatment of pancreatic ductal adenocarcinoma. Zhou H; Wang W; Cai Z; Jia ZY; Li YY; He W; Li C; Zhang BL J Nanobiotechnology; 2024 Jun; 22(1):353. PubMed ID: 38902759 [TBL] [Abstract][Full Text] [Related]
9. Losartan treatment enhances chemotherapy efficacy and reduces ascites in ovarian cancer models by normalizing the tumor stroma. Zhao Y; Cao J; Melamed A; Worley M; Gockley A; Jones D; Nia HT; Zhang Y; Stylianopoulos T; Kumar AS; Mpekris F; Datta M; Sun Y; Wu L; Gao X; Yeku O; Del Carmen MG; Spriggs DR; Jain RK; Xu L Proc Natl Acad Sci U S A; 2019 Feb; 116(6):2210-2219. PubMed ID: 30659155 [TBL] [Abstract][Full Text] [Related]
10. Pathophysiological role of microRNA-29 in pancreatic cancer stroma. Kwon JJ; Nabinger SC; Vega Z; Sahu SS; Alluri RK; Abdul-Sater Z; Yu Z; Gore J; Nalepa G; Saxena R; Korc M; Kota J Sci Rep; 2015 Jun; 5():11450. PubMed ID: 26095125 [TBL] [Abstract][Full Text] [Related]
11. Stromal Homeostasis-Restoring Nanomedicine Enhances Pancreatic Cancer Chemotherapy. Yu N; Zhang X; Zhong H; Mu J; Li X; Liu T; Shi X; Liang XJ; Guo S Nano Lett; 2022 Nov; 22(21):8744-8754. PubMed ID: 36279310 [TBL] [Abstract][Full Text] [Related]
12. Novel lipophilic SN38 prodrug forming stable liposomes for colorectal carcinoma therapy. Xing J; Zhang X; Wang Z; Zhang H; Chen P; Zhou G; Sun C; Gu N; Ji M Int J Nanomedicine; 2019; 14():5201-5213. PubMed ID: 31371956 [No Abstract] [Full Text] [Related]
13. Disulfide Bond-Based SN38 Prodrug Nanoassemblies with High Drug Loading and Reduction-Triggered Drug Release for Pancreatic Cancer Therapy. Zhong ZX; Li XZ; Liu JT; Qin N; Duan HQ; Duan XC Int J Nanomedicine; 2023; 18():1281-1298. PubMed ID: 36945256 [TBL] [Abstract][Full Text] [Related]
14. C4b-binding protein α-chain enhances antitumor immunity by facilitating the accumulation of tumor-infiltrating lymphocytes in the tumor microenvironment in pancreatic cancer. Sasaki K; Takano S; Tomizawa S; Miyahara Y; Furukawa K; Takayashiki T; Kuboki S; Takada M; Ohtsuka M J Exp Clin Cancer Res; 2021 Jun; 40(1):212. PubMed ID: 34167573 [TBL] [Abstract][Full Text] [Related]
15. Nanomedicine Strategies to Enhance Tumor Drug Penetration in Pancreatic Cancer. Lu T; Prakash J Int J Nanomedicine; 2021; 16():6313-6328. PubMed ID: 34552327 [TBL] [Abstract][Full Text] [Related]
16. Novel carrier-free nanoparticles composed of 7-ethyl-10-hydroxycamptothecin and chlorin e6: Self-assembly mechanism investigation and in vitro/in vivo evaluation. Zhao Y; Zhao Y; Ma Q; Zhang H; Liu Y; Hong J; Ding Z; Liu M; Han J Colloids Surf B Biointerfaces; 2020 Apr; 188():110722. PubMed ID: 31887649 [TBL] [Abstract][Full Text] [Related]
17. Collagenase Nanoparticles Enhance the Penetration of Drugs into Pancreatic Tumors. Zinger A; Koren L; Adir O; Poley M; Alyan M; Yaari Z; Noor N; Krinsky N; Simon A; Gibori H; Krayem M; Mumblat Y; Kasten S; Ofir S; Fridman E; Milman N; Lübtow MM; Liba L; Shklover J; Shainsky-Roitman J; Binenbaum Y; Hershkovitz D; Gil Z; Dvir T; Luxenhofer R; Satchi-Fainaro R; Schroeder A ACS Nano; 2019 Oct; 13(10):11008-11021. PubMed ID: 31503443 [TBL] [Abstract][Full Text] [Related]
18. Deep-Penetrating Triple-Responsive Prodrug Nanosensitizer Actuates Efficient Chemoradiotherapy in Pancreatic Ductal Adenocarcinoma Models. Tang X; Du X; Yu Y; Qin M; Qian L; Zhang M; Yang Y; Yu Q; Gan Z Small; 2022 Aug; 18(31):e2202834. PubMed ID: 35808966 [TBL] [Abstract][Full Text] [Related]
19. Targeting the Tumor Core: Hypoxia-Responsive Nanoparticles for the Delivery of Chemotherapy to Pancreatic Tumors. Confeld MI; Mamnoon B; Feng L; Jensen-Smith H; Ray P; Froberg J; Kim J; Hollingsworth MA; Quadir M; Choi Y; Mallik S Mol Pharm; 2020 Aug; 17(8):2849-2863. PubMed ID: 32521162 [TBL] [Abstract][Full Text] [Related]
20. Targeting cancer-associated fibroblasts by dual-responsive lipid-albumin nanoparticles to enhance drug perfusion for pancreatic tumor therapy. Yu Q; Qiu Y; Li J; Tang X; Wang X; Cun X; Xu S; Liu Y; Li M; Zhang Z; He Q J Control Release; 2020 May; 321():564-575. PubMed ID: 32112854 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]